Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Rectal Neoplasms
Interventions
OTHER

Early MRI and PET/CT - 2 weeks after commencing chemo/RT

Patients will have an early MRI and PET/CT - 2 weeks after commencing chemo/RT. A limited range PET/CT will look at parameters: SUVmaxm PERCIST, RECIST 1.1, ΔSUV (PET1-2), ΔSUV (early -late), Glycolytic tumour volume (GTV). MRI T2 (1-3mm slice as per NS Radiology protocol and ESGAR guideline) will look at parameters: DWI \& ADC value (preferably on a single camera with reproducible ADC value), Local Staging, MRF involvement, EMVI, nodal status, MR volumetry, and desmoplastic reaction.

OTHER

Late MRI and PET/CT 6 weeks post chemo/RT

Patients will have late a MRI and PET/CT 6 weeks post chemo/RT. A whole body PET/CT will look at parameters: SUVmaxm PERCIST, RECIST 1.1, ΔSUV (PET1-2), ΔSUV (early -late), Glycolytic tumour volume (GTV). MRI T2 (1-3mm slice as per NS Radiology protocol and ESGAR guideline) will look at parameters: DWI \& ADC value (preferably on a single camera with reproducible ADC value), Local Staging, MRF involvement, EMVI, nodal status, MR volumetry, and desmoplastic reaction.

Trial Locations (1)

2065

Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards

All Listed Sponsors
lead

Royal North Shore Hospital

OTHER

NCT02233374 - Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET | Biotech Hunter | Biotech Hunter